161 related articles for article (PubMed ID: 10403538)
1. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.
Brueggemeier RW; Quinn AL; Parrett ML; Joarder FS; Harris RE; Robertson FM
Cancer Lett; 1999 Jun; 140(1-2):27-35. PubMed ID: 10403538
[TBL] [Abstract][Full Text] [Related]
2. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA; Petrel TA; Brueggemeier RW
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
[TBL] [Abstract][Full Text] [Related]
3. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
[TBL] [Abstract][Full Text] [Related]
4. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
Brueggemeier RW; Díaz-Cruz ES
Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
[TBL] [Abstract][Full Text] [Related]
5. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer.
Harris RE; Robertson FM; Abou-Issa HM; Farrar WB; Brueggemeier R
Med Hypotheses; 1999 Apr; 52(4):291-2. PubMed ID: 10465664
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.
Díaz-Cruz ES; Brueggemeier RW
Anticancer Agents Med Chem; 2006 May; 6(3):221-32. PubMed ID: 16712450
[TBL] [Abstract][Full Text] [Related]
7. Aromatase and cyclooxygenases: enzymes in breast cancer.
Brueggemeier RW; Richards JA; Petrel TA
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):501-7. PubMed ID: 14623550
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma].
Pang D; Zhao X; Xue Y
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327
[TBL] [Abstract][Full Text] [Related]
10. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
[TBL] [Abstract][Full Text] [Related]
11. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
Díaz-Cruz ES; Shapiro CL; Brueggemeier RW
J Clin Endocrinol Metab; 2005 May; 90(5):2563-70. PubMed ID: 15687328
[TBL] [Abstract][Full Text] [Related]
14. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
16. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
Badawi AF; Badr MZ
Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2006 Apr; 118(8):1915-21. PubMed ID: 16287071
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms.
Hardy DB; Janowski BA; Chen CC; Mendelson CR
Mol Endocrinol; 2008 Aug; 22(8):1812-24. PubMed ID: 18483177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
